Global Antithyroid Medications for Hyperthyroidism Market Growth 2023-2029

Global Antithyroid Medications for Hyperthyroidism Market Growth 2023-2029

The global Antithyroid Medications for Hyperthyroidism market size is projected to grow from US$ 443.1 million in 2022 to US$ 687.4 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.

United States market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Antithyroid Medications for Hyperthyroidism players cover Merck, Herbrand PharmaChemicals, Future Health Pharma, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical and Guangdong Huanan Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.

LPI (LP Information)' newest research report, the “Antithyroid Medications for Hyperthyroidism Industry Forecast” looks at past sales and reviews total world Antithyroid Medications for Hyperthyroidism sales in 2022, providing a comprehensive analysis by region and market sector of projected Antithyroid Medications for Hyperthyroidism sales for 2023 through 2029. With Antithyroid Medications for Hyperthyroidism sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antithyroid Medications for Hyperthyroidism industry.

This Insight Report provides a comprehensive analysis of the global Antithyroid Medications for Hyperthyroidism landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antithyroid Medications for Hyperthyroidism portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antithyroid Medications for Hyperthyroidism market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antithyroid Medications for Hyperthyroidism and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antithyroid Medications for Hyperthyroidism.

This report presents a comprehensive overview, market shares, and growth opportunities of Antithyroid Medications for Hyperthyroidism market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Methimazole
Propylthiouracil
Other

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Herbrand PharmaChemicals
Future Health Pharma
Shanghai Zhaohui Pharmaceutical
Beijing Yanjing Pharmaceutical
Jinghua Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical
Zigong Honghe Pharmaceutical
Guangdong Huanan Pharmaceutical
Zibo Wankang Pharmaceutical Chemical
Qilu Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antithyroid Medications for Hyperthyroidism market?

What factors are driving Antithyroid Medications for Hyperthyroidism market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antithyroid Medications for Hyperthyroidism market opportunities vary by end market size?

How does Antithyroid Medications for Hyperthyroidism break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.